Publicacións en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (19)

2022

  1. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network

    European Journal of Pediatrics, Vol. 181, Núm. 2, pp. 789-799

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2013

  1. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

2011

  1. Invasive fungal infections in onco-haematology: A spanish perspective

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 3, pp. 168-172

  2. Retraso diagnóstico de la infección por el VIH en Andalucía

    Enfermedades Infecciosas y Microbiologia Clinica

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

1998

  1. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach

    Haematologica, Vol. 83, Núm. 7, pp. 616-621

1997

  1. Sustained trilineage response to erythropoietin therapy in a case of aplastic anaemia (multiple letters)

    Journal of Internal Medicine

1996

  1. ESTUDIO COMPARATIVO DE LA ESTABILIDAD DEL TRATAMIENTO ANTICOAGULANTE ORAL (WARFARINA VERSUS ACENOCUMAROL)

    Sangre, Vol. 41, Núm. 1, pp. 9-11

  2. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388

  3. Persistent polyclonal B lymphocytosis [4]

    American Journal of Hematology

1995

  1. Sternal mass as first manifestation of Hodgkin's disease

    European Journal of Internal Medicine, Vol. 6, Núm. 3, pp. 191-192

1994

  1. Hodgkin's disease and HIV: relations between CD4/CD8 rate, histology and stage

    Revista clínica española, Vol. 194, Núm. 7, pp. 543-546

  2. Ticlopidine and severe aplastic anemia

    American Journal of Hematology